Drug delivery systems for programmed and on-demand release

Tabata, 2000, The importance of drug delivery systems in tissue engineering, Pharm. Sci. Technol. Today, 3, 80, 10.1016/S1461-5347(00)00242-X Langer, 2000, Biomaterials in drug delivery and tissue engineering: one laboratory's experience, Acc. Chem. Res., 33, 94, 10.1021/ar9800993 Shi, 2010, Nanotechnology in drug delivery and tissue engineering: from discovery to applications, Nano Lett., 10, 3223, 10.1021/nl102184c Skiles, 2013, Polymeric drug delivery systems in tissue engineering, 227 Kakkar, 2017, Evolution of macromolecular complexity in drug delivery systems, Nat. Rev. Chem., 1, 0063, 10.1038/s41570-017-0063 Guo, 2016, Polymer-based drug delivery systems for cancer treatment, J. Polym. Sci. A Polym. Chem., 54, 3525, 10.1002/pola.28252 2009, Nat. Rev. Drug Discov., 8, 87, 10.1038/nrd2791 Wertheimer, 2005, Drug delivery systems improve pharmaceutical profile and facilitate medication adherence, Adv. Ther., 22, 559, 10.1007/BF02849950 Kumari, 2010, Biodegradable polymeric nanoparticles based drug delivery systems, Colloids Surf. B: Biointerfaces, 75, 1, 10.1016/j.colsurfb.2009.09.001 Urquhart, 2000, Erratic patient compliance with prescribed drug regimens: target for drug delivery systems, Clin. Pharmacol. Ther., 67, 331, 10.1067/mcp.2000.105582 Rosen, 2005, The rise and rise of drug delivery, Nat. Rev. Drug Discov., 4, 381, 10.1038/nrd1721 Jain, 2013, Peptide and protein delivery using new drug delivery systems, Crit. Rev. Ther. Drug Carrier Syst., 30, 293, 10.1615/CritRevTherDrugCarrierSyst.2013006955 Ibraheem, 2014, Gene therapy and DNA delivery systems, Int. J. Pharm., 459, 70, 10.1016/j.ijpharm.2013.11.041 Sinha, 2003, Biodegradable microspheres for protein delivery, J. Control. Release, 90, 261, 10.1016/S0168-3659(03)00194-9 Bruno, 2013, Basics and recent advances in peptide and protein drug delivery, Ther. Deliv., 4, 1443, 10.4155/tde.13.104 Muheem, 2016, A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives, Saudi Pharm. J., 24, 413, 10.1016/j.jsps.2014.06.004 Yun, 2014, Controlled drug delivery systems: the next 30 years, Front. Chem. Sci. Eng., 8, 276, 10.1007/s11705-014-1426-x Hoffman, 2008, The origins and evolution of “controlled” drug delivery systems, J. Control. Release, 132, 153, 10.1016/j.jconrel.2008.08.012 Khanna, 1970, Bead polymerization technique for sustained-release dosage form, J. Pharm. Sci., 59, 614, 10.1002/jps.2600590508 Birrenbach, 1976, Polymerized micelles and their use as adjuvants in immunology, J. Pharm. Sci., 65, 1763, 10.1002/jps.2600651217 Heller, 1980, Controlled release of biologically active compounds from bioerodible polymers, Biomaterials, 1, 51, 10.1016/0142-9612(80)90060-5 Heller, 1985, Controlled drug release from poly(ortho esters), Ann. N. Y. Acad. Sci., 446, 51, 10.1111/j.1749-6632.1985.tb18390.x Heller, 1985, Poly(ortho ester) biodegradable polymer systems, Methods Enzymol., 112, 422, 10.1016/S0076-6879(85)12033-1 Langer, 1990, Future directions in biomaterials, Biomaterials, 11, 738, 10.1016/0142-9612(90)90038-R Folkman, 1964, The use of silicone rubber as a carrier for prolonged drug therapy, J. Surg. Res., 4, 139, 10.1016/S0022-4804(64)80040-8 Roseman, 1972, Release of steroids from a silicone polymer, J. Pharm. Sci., 61, 46, 10.1002/jps.2600610106 Przybylski, 1978, DIVEMA-methotrexate: immune-adjuvant role of polymeric carriers linked to antitumor agents, Cancer Treat. Rep., 62, 1837 Peppas, 1977, Development of semicrystalline poly(vinyl alcohol) hydrogels for biomedical applications, J. Biomed. Mater. Res., 11, 423, 10.1002/jbm.820110309 Batz, 1972, Model reactions for synthesis of pharmacologically active polymers by way of monomeric and polymeric reactive esters, Angew. Chem. Int. Ed. Eng., 11, 1103, 10.1002/anie.197211031 Langer, 2003, Advances in biomaterials, drug delivery, and bionanotechnology, AIChE J., 49, 2990, 10.1002/aic.690491202 Langer, 1976, Polymers for the sustained release of proteins and other macromolecules, Nature, 263, 797, 10.1038/263797a0 Langer, 1983, Implantable controlled release systems, Pharmacol. Ther., 21, 35, 10.1016/0163-7258(83)90066-9 Cullins, 1992, Injectable and implantable contraceptives, Curr. Opin. Obstet. Gynecol., 4, 536, 10.1097/00001703-199208000-00008 McCoy, 2010, Triggered drug delivery from biomaterials, Expert Opin. Drug Deliv., 7, 605, 10.1517/17425241003677731 Sershen, 2002, Implantable, polymeric systems for modulated drug delivery, Adv. Drug Deliv. Rev., 54, 1225, 10.1016/S0169-409X(02)00090-X Liu, 2016, The smart drug delivery system and its clinical potential, Theranostics, 6, 1306, 10.7150/thno.14858 Jaimes-Aguirre, 2016, Polymer-based drug delivery systems, development and pre-clinical status, Curr. Pharm. Des., 22, 2886, 10.2174/1381612822666160217125028 Rodzinski, 2016, Targeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticles, Sci. Rep., 6, 10.1038/srep20867 Tsuchida, 2011, Drug delivery systems for cancer treatment, 1160 Kanoff, 1994, Intraspinal delivery of opiates by an implantable, programmable pump in patients with chronic, intractable pain of nonmalignant origin, J. Am. Osteopath. Assoc., 94, 487, 10.7556/jaoa.1994.94.6.487 Hoekstra, 1994, Pain relief mediated by implantable drug delivery devices, Int. J. Artif. Organs, 17, 151, 10.1177/039139889401700305 Veiseh, 2014, Managing diabetes with nanomedicine: challenges and opportunities, Nat. Rev. Drug Discov., 14, 45, 10.1038/nrd4477 Grover, 2014, Recent advances in drug delivery systems for anti-diabetic drugs: a review, Curr. Drug Deliv., 11, 444, 10.2174/1567201811666140118225021 Rai, 2016, Novel drug delivery system: an immense hope for diabetics, Drug Deliv., 23, 2371, 10.3109/10717544.2014.991001 Thompson, 2014, Drug delivery to the ischemic brain, Adv. Pharmacol., 71, 165, 10.1016/bs.apha.2014.06.013 Tornabene, 2016, Stroke and drug delivery—in vitro models of the ischemic blood-brain barrier, J. Pharm. Sci., 105, 398, 10.1016/j.xphs.2015.11.041 Rhim, 2013, Drug delivery systems for the treatment of ischemic stroke, Pharm. Res., 30, 2429, 10.1007/s11095-012-0959-2 Zhang, 2017, Direct macromolecular drug delivery to cerebral ischemia area using neutrophil-mediated nanoparticles, Theranostics, 7, 3260, 10.7150/thno.19979 Galagudza, 2010, Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization, natural biodistribution, and acute toxicity, Int. J. Nanomedicine, 5, 231, 10.2147/IJN.S8719 Joshi, 2015, Nanofibers based tissue engineering and drug delivery approaches for myocardial regeneration, Curr. Pharm. Des., 21, 2006, 10.2174/1381612821666150302153138 Hastings, 2015, Drug and cell delivery for cardiac regeneration, Adv. Drug Deliv. Rev., 84, 85, 10.1016/j.addr.2014.08.006 Johnson, 2013, Injectable hydrogel therapies and their delivery strategies for treating myocardial infarction, Expert Opin. Drug Deliv., 10, 59, 10.1517/17425247.2013.739156 Saroja, 2011, Recent trends in vaccine delivery systems: a review, Int. J. Pharm. Investig., 1, 64, 10.4103/2230-973X.82384 Levin, 2005, Transdermal delivery of human growth hormone through RF-microchannels, Pharm. Res., 22, 550, 10.1007/s11095-005-2498-6 Arora, 2008, Micro-scale devices for transdermal drug delivery, Int. J. Pharm., 364, 227, 10.1016/j.ijpharm.2008.08.032 Glenn, 2006, Mass vaccination: solutions in the skin, Curr. Top. Microbiol. Immunol., 304, 247 Thambi, 2016, Poly(ethylene glycol)-b-poly(lysine) copolymer bearing nitroaromatics for hypoxia-sensitive drug delivery, Acta Biomater., 29, 261, 10.1016/j.actbio.2015.10.011 Guarnieri, 2015, Tumor-activated prodrug (TAP)-conjugated nanoparticles with cleavable domains for safe doxorubicin delivery, Biotechnol. Bioeng., 112, 601, 10.1002/bit.25454 Kim, 2017, Reversibly pH-responsive polyurethane membranes for on-demand intravaginal drug delivery, Acta Biomater., 47, 100, 10.1016/j.actbio.2016.10.006 Davoodi, 2016, Synthesis of intracellular reduction-sensitive amphiphilic polyethyleneimine and poly(ε-caprolactone) graft copolymer for on-demand release of doxorubicin and p53 plasmid DNA, Acta Biomater., 39, 79, 10.1016/j.actbio.2016.05.003 Kamaly, 2016, Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release, Chem. Rev., 116, 2602, 10.1021/acs.chemrev.5b00346 Wei, 2017, Thermo-sensitive polypeptide hydrogel for locally sequential delivery of two-pronged antitumor drugs, Acta Biomater., 58, 44, 10.1016/j.actbio.2017.05.053 Unsoy, 2014, Synthesis of doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery, Eur. J. Pharm. Sci., 62, 243, 10.1016/j.ejps.2014.05.021 Cui, 2017, Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin, Acta Pharmacol. Sin., 38, 943, 10.1038/aps.2017.45 Papa, 2017, Ultrasound-sensitive nanoparticle aggregates for targeted drug delivery, Biomaterials, 139, 187, 10.1016/j.biomaterials.2017.06.003 Palo, 2017, 3D printed drug delivery devices: perspectives and technical challenges, Expert Rev. Med. Devices, 14, 685, 10.1080/17434440.2017.1363647 Zhang, 2017, Microfabricated drug delivery devices: design, fabrication, and applications, Adv. Funct. Mater., 27, 10.1002/adfm.201703606 Staples, 2006, Application of micro- and nano-electromechanical devices to drug delivery, Pharm. Res., 23, 847, 10.1007/s11095-006-9906-4 LaVan, 2003, Small-scale systems for in vivo drug delivery, Nat. Biotechnol., 21, 1184, 10.1038/nbt876 Brudno, 2015, On-demand drug delivery from local depots, J. Control. Release, 219, 8, 10.1016/j.jconrel.2015.09.011 Fredenberg, 2011, The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—a review, Int. J. Pharm., 415, 34, 10.1016/j.ijpharm.2011.05.049 Anderson, 2012, Biodegradation and biocompatibility of PLA and PLGA microspheres, Adv. Drug Deliv. Rev., 64, 72, 10.1016/j.addr.2012.09.004 Uhrich, 1999, Polymeric systems for controlled drug release, Chem. Rev., 99, 3181, 10.1021/cr940351u Arifin, 2006, Mathematical modeling and simulation of drug release from microspheres: implications to drug delivery systems, Adv. Drug Deliv. Rev., 58, 1274, 10.1016/j.addr.2006.09.007 Tran, 2011, Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy?, Int. J. Pharm., 407, 1, 10.1016/j.ijpharm.2011.01.027 Feng, 2017, Coaxial double-walled microspheres for combined release of cytochrome c and doxorubicin, J. Control. Release, 259, e30, 10.1016/j.jconrel.2017.03.088 Park, 2005, Biodegradable polymers for microencapsulation of drugs, Molecules, 10, 146, 10.3390/10010146 Liechty, 2010, Polymers for drug delivery systems, Annu. Rev. Chem. Biomol. Eng., 1, 149, 10.1146/annurev-chembioeng-073009-100847 Siepmann, 2012, Modeling of diffusion controlled drug delivery, J. Control. Release, 161, 351, 10.1016/j.jconrel.2011.10.006 Wischke, 2008, Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles, Int. J. Pharm., 364, 298, 10.1016/j.ijpharm.2008.04.042 Harland, 1988, A model of dissolution-controlled, diffusional drug release from non-swellable polymeric microspheres, J. Control. Release, 7, 207, 10.1016/0168-3659(88)90053-3 Li, 2008, Microencapsulation by solvent evaporation: state of the art for process engineering approaches, Int. J. Pharm., 363, 26, 10.1016/j.ijpharm.2008.07.018 Food, D. Administration, 2000 Vimalson, 2016, Techniques to enhance solubility of hydrophobic drugs: an overview, Asian J. Pharm. Sci., 10, S67 Polakovic, 1999, Lidocaine loaded biodegradable nanospheres. II. modelling of drug release, J. Control. Release, 60, 169, 10.1016/S0168-3659(99)00012-7 Lee, 2008, Supercritical antisolvent production of biodegradable micro- and nanoparticles for controlled delivery of paclitaxel, J. Control. Release, 125, 96, 10.1016/j.jconrel.2007.10.002 Zhang, 2006, A dissolution-diffusion model and quantitative analysis of drug controlled release from biodegradable polymer microspheres, Can. J. Chem. Eng., 84, 558, 10.1002/cjce.5450840507 Lamprecht, 2003, Microsphere design for the colonic delivery of 5-fluorouracil, J. Control. Release, 90, 313, 10.1016/S0168-3659(03)00195-0 Naraharisetti, 2005, Gentamicin-loaded discs and microspheres and their modifications: characterization and in vitro release, J. Control. Release, 102, 345, 10.1016/j.jconrel.2004.10.016 Wang, 2015, Polymer hydrophobicity regulates paclitaxel distribution in microspheres, release profile and cytotoxicity in vitro, Powder Technol., 275, 77, 10.1016/j.powtec.2015.01.041 Campardelli, 2016, Supercritical assisted injection in a liquid antisolvent for PLGA and PLA microparticle production, Powder Technol., 287, 12, 10.1016/j.powtec.2015.09.035 Prabhakaran, 2015, Electrospraying technique for the fabrication of metronidazole contained PLGA particles and their release profile, Mater. Sci. Eng. C, 56, 66, 10.1016/j.msec.2015.06.018 Nihant, 1995, Microencapsulation by coacervation of poly(lactide-co-glycolide) IV. Effect of the processing parameters on coacervation and encapsulation, J. Control. Release, 35, 117, 10.1016/0168-3659(95)00026-5 Nie, 2007, Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA, J. Control. Release, 120, 111, 10.1016/j.jconrel.2007.03.018 Lavin, 2013, Effects of protein molecular weight on the intrinsic material properties and release kinetics of wet spun polymeric microfiber delivery systems, Acta Biomater., 9, 4569, 10.1016/j.actbio.2012.08.005 Pang, 2011, Ibuprofen-loaded poly(lactic-co-glycolic acid) films for controlled drug release, Int. J. Nanomedicine, 6, 659 Steele, 2011, The effect of polyethylene glycol structure on paclitaxel drug release and mechanical properties of PLGA thin films, Acta Biomater., 7, 1973, 10.1016/j.actbio.2011.02.002 Nam, 1999, Biodegradable polymeric microcellular foams by modified thermally induced phase separation method, Biomaterials, 20, 1783, 10.1016/S0142-9612(99)00073-3 Lee, 2009, Paclitaxel release from micro-porous PLGA disks, Chem. Eng. Sci., 64, 4341, 10.1016/j.ces.2009.07.016 Hines, 2013, Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights, Crit. Rev. Ther. Drug Carrier Syst., 30, 257, 10.1615/CritRevTherDrugCarrierSyst.2013006475 Kim, 2012, Application of a dissolusion-diffusion model to the release of 5-fluorouracil from polymer microspheres, Chem. Eng. Commun., 199, 587, 10.1080/00986445.2011.604811 Wang, 2001, A new nerve guide conduit material composed of a biodegradable poly(phosphoester), Biomaterials, 22, 1157, 10.1016/S0142-9612(00)00356-2 Raza, 2018, Polyhydroxyalkanoates: characteristics, production, recent developments and applications, Int. Biodeterior. Biodegrad., 126, 45, 10.1016/j.ibiod.2017.10.001 Anjum, 2016, Microbial production of polyhydroxyalkanoates (PHAs) and its copolymers: a review of recent advancements, Int. J. Biol. Macromol., 89, 161, 10.1016/j.ijbiomac.2016.04.069 Shrivastav, 2013, Advances in the applications of polyhydroxyalkanoate nanoparticles for novel drug delivery system, Biomed. Res. Int., 2013, 581684, 10.1155/2013/581684 Heller, 2000, Poly(ortho esters) - their development and some recent applications, Eur. J. Pharm. Biopharm., 50, 121, 10.1016/S0939-6411(00)00085-0 Uhrich, 1998, Chemical changes during in vivo degradation of poly(anhydride-imide) matrices, Biomaterials, 19, 2045, 10.1016/S0142-9612(98)00110-0 Erdmann, 2000, Synthesis and degradation characteristics of salicylic acid-derived poly(anhydride-esters), Biomaterials, 21, 1941, 10.1016/S0142-9612(00)00073-9 Fonseca, 2014, Biodegradable poly(ester amide)s – a remarkable opportunity for the biomedical area: review on the synthesis, characterization and applications, Prog. Polym. Sci., 39, 1291, 10.1016/j.progpolymsci.2013.11.007 Lao, 2008, Modeling of drug release from biodegradable polymer blends, Eur. J. Pharm. Biopharm., 70, 796, 10.1016/j.ejpb.2008.05.024 Merkle, 2015, Drug delivery's quest for polymers: where are the frontiers?, Eur. J. Pharm. Biopharm., 97, 293, 10.1016/j.ejpb.2015.04.038 Anselmo, 2014, An overview of clinical and commercial impact of drug delivery systems, J. Control. Release, 190, 15, 10.1016/j.jconrel.2014.03.053 Ong, 2009, Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme, Biomaterials, 30, 3189, 10.1016/j.biomaterials.2009.02.030 Wright, 2011 K. Sasaki, G.C. Kabushiki, C. Abstracts, P.E.E. Waddell, US Patent, 1976, pp. 575–585. Lavin, 2012, Multifunctional polymeric microfibers with prolonged drug delivery and structural support capabilities, Acta Biomater., 8, 1891, 10.1016/j.actbio.2012.01.019 A.zeusinc.com S.F. Stellenbosch Nanofiber Company Cabezas, 2012, Production of biodegradable porous scaffolds impregnated with indomethacin in supercritical CO2, J. Supercrit. Fluids, 63, 155, 10.1016/j.supflu.2011.12.002 Cabezas, 2013, Production of biodegradable porous scaffolds impregnated with 5-fluorouracil in supercritical CO2, J. Supercrit. Fluids, 80, 1, 10.1016/j.supflu.2013.03.030 Ong, 2018, Production of drug-releasing biodegradable microporous scaffold using a two-step micro-encapsulation/supercritical foaming process, J. Supercrit. Fluids, 133, 263, 10.1016/j.supflu.2017.10.018 Freitas, 2005, Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology, J. Control. Release, 102, 313, 10.1016/j.jconrel.2004.10.015 Klose, 2008, PLGA-based drug delivery systems: importance of the type of drug and device geometry, Int. J. Pharm., 354, 95, 10.1016/j.ijpharm.2007.10.030 Mu, 2002, Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol), J. Control. Release, 80, 129, 10.1016/S0168-3659(02)00025-1 Kim, 2013, Doxorubicin-loaded porous PLGA microparticles with surface attached TRAIL for the inhalation treatment of metastatic lung cancer, Biomaterials, 34, 6444, 10.1016/j.biomaterials.2013.05.018 Chaisri, 2011, Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters, Colloids Surf. B: Biointerfaces, 84, 508, 10.1016/j.colsurfb.2011.02.006 Vicente, 2013, Fundamental analysis of particle formation in spray drying, Powder Technol., 247, 1, 10.1016/j.powtec.2013.06.038 Nandiyanto, 2011, Progress in developing spray-drying methods for the production of controlled morphology particles: from the nanometer to submicrometer size ranges, Adv. Powder Technol., 22, 1, 10.1016/j.apt.2010.09.011 Yao, 2008, Characterization of electrospraying process for polymeric particle fabrication, J. Aerosol Sci., 39, 987, 10.1016/j.jaerosci.2008.07.003 Ciach, 2007, Application of electro-hydro-dynamic atomization in drug delivery, J. Drug Delivery Sci. Technol., 17, 367, 10.1016/S1773-2247(07)50076-6 Xie, 2006, Electrohydrodynamic atomization for biodegradable polymeric particle production, J. Colloid Interface Sci., 302, 103, 10.1016/j.jcis.2006.06.037 Bock, 2012, Electrospraying of polymers with therapeutic molecules: state of the art, Prog. Polym. Sci., 37, 1510, 10.1016/j.progpolymsci.2012.03.002 Davoodi, 2015, Coaxial electrohydrodynamic atomization: microparticles for drug delivery applications, J. Control. Release, 205, 70, 10.1016/j.jconrel.2014.12.004 Xie, 2015, Electrohydrodynamic atomization: a two-decade effort to produce and process micro-/nanoparticulate materials, Chem. Eng. Sci., 125, 32, 10.1016/j.ces.2014.08.061 Nuchuchua, 2017, Characterization of drug delivery particles produced by supercritical carbon dioxide technologies, J. Supercrit. Fluids, 128, 244, 10.1016/j.supflu.2017.06.002 Tsivintzelis, 2016, Foaming of polymers with supercritical fluids: a thermodynamic investigation, J. Supercrit. Fluids, 110, 240, 10.1016/j.supflu.2015.11.025 Zhang, 2012, Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique, Int. J. Pharm., 436, 272, 10.1016/j.ijpharm.2012.06.022 Elizondo, 2011, High loading of gentamicin in bioadhesive PVM/MA nanostructured microparticles using compressed carbon-dioxide, Pharm. Res., 28, 309, 10.1007/s11095-010-0248-x Davies, 2008, Applications of supercritical CO2 in the fabrication of polymer systems for drug delivery and tissue engineering, Adv. Drug Deliv. Rev., 60, 373, 10.1016/j.addr.2006.12.001 Siepmann, 2012, Diffusion controlled drug delivery systems, 127 Kim, 2000 Tanquary, 1974 Paul, 1976, Diffusional release of a solute from a polymer matrix, J. Membr. Sci., 1, 33, 10.1016/S0376-7388(00)82256-5 Fan, 1989, Diffusion-controlled release, 9 Higuchi, 1961, Rate of release of medicaments from ointment bases containing drugs in suspension, J. Pharm. Sci., 50, 874, 10.1002/jps.2600501018 Cooney, 1972, Effect of geometry on the dissolution of pharmaceutical tablets and other solids: surface detachment kinetics controlling, AICHE J., 18, 446, 10.1002/aic.690180234 El-Arini, 1998, Dissolution properties of praziquantel–PVP systems, Pharm. Acta Helv., 73, 89, 10.1016/S0031-6865(97)00051-4 Hopfenberg, 1976, Controlled release from erodible slabs, cylinders, and spheres, 26 Weibull, 1951, A statistical distribution function of wide applicability, J. Appl. Mech., 18, 293, 10.1115/1.4010337 Charlier, 2000, Release of mifepristone from biodegradable matrices: experimental and theoretical evaluations, Int. J. Pharm., 200, 115, 10.1016/S0378-5173(00)00356-2 Raman, 2005, Modeling small-molecule release from PLG microspheres: effects of polymer degradation and nonuniform drug distribution, J. Control. Release, 103, 149, 10.1016/j.jconrel.2004.11.012 He, 2005, Modeling of drug release from bioerodible polymer matrices, Drug Deliv., 12, 251, 10.1080/10717540500176043 Baker, 1974 Fitzgerald, 1993, Mechanisms governing drug release from poly-α-hydroxy aliphatic esters: diltiazem base release from poly-lactide-co-glycolide delivery systems, Polymp Delivp Sysp, 311, 10.1021/bk-1993-0520.ch023 Wischke, 2012, Degradable polymeric carriers for parenteral controlled drug delivery, 171 Allison, 2008, Analysis of initial burst in PLGA microparticles, Expert Opin. Drug Deliv., 5, 615, 10.1517/17425247.5.6.615 Wakiyama, 1981, Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics, Chem. Pharm. Bull.(Tokyo), 29, 3363, 10.1248/cpb.29.3363 Jalil, 1989, Microencapsulation using poly(l-lactic acid). I: microcapsule properties affected by the preparative technique, J. Microencapsul., 6, 473, 10.3109/02652048909031167 Wischke, 2010, Comparing techniques for drug loading of shape-memory polymer networks—effect on their functionalities, Eur. J. Pharm. Sci., 41, 136, 10.1016/j.ejps.2010.06.003 Wischke, 2009, Evaluation of a degradable shape-memory polymer network as matrix for controlled drug release, J. Control. Release, 138, 243, 10.1016/j.jconrel.2009.05.027 Wang, 2002, Characterization of the initial burst release of a model peptide from poly(d,l-lactide-co-glycolide) microspheres, J. Control. Release, 82, 289, 10.1016/S0168-3659(02)00137-2 Zhao, 2017, Development of near zero-order release PLGA-based microspheres of a novel antipsychotic, Int. J. Pharm., 516, 32, 10.1016/j.ijpharm.2016.11.007 Vora, 2017, Zero order controlled release delivery of cholecalciferol from injectable biodegradable microsphere: in-vitro characterization and in-vivo pharmacokinetic studies, Eur. J. Pharm. Sci., 107, 78, 10.1016/j.ejps.2017.06.027 Park, 1994, Degradation of poly(d,l-lactic acid) microspheres: effect of molecular weight, J. Control. Release, 30, 161, 10.1016/0168-3659(94)90263-1 Ravivarapu, 2000, Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres, Eur. J. Pharm. Biopharm., 50, 263, 10.1016/S0939-6411(00)00099-0 Mi, 2002, Chitin/PLGA blend microspheres as a biodegradable drug-delivery system: phase-separation, degradation and release behavior, Biomaterials, 23, 3257, 10.1016/S0142-9612(02)00084-4 Lavelle, 1999, The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol, Vaccine, 17, 512, 10.1016/S0264-410X(98)00229-1 Zhang, 1997, Effects of metal salts on poly(dl-lactide-co-glycolide) polymer hydrolysis, J. Biomed. Mater. Res., 34, 531, 10.1002/(SICI)1097-4636(19970315)34:4<531::AID-JBM13>3.0.CO;2-F Berkland, 2002, Precise control of PLG microsphere size provides enhanced control of drug release rate, J. Control. Release, 82, 137, 10.1016/S0168-3659(02)00136-0 Langer, 1981, Present and future applications of biomaterials in controlled drug delivery systems, Biomaterials, 2, 201, 10.1016/0142-9612(81)90059-4 Johnson, 2009, Concurrent release of admixed antimicrobials and salicylic acid from salicylate-based poly(anhydride-esters), J. Biomed. Mater. Res. A, 91, 671, 10.1002/jbm.a.32288 Lopac, 2009, Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres, J Biomed Mater Res B Appl Biomater, 91, 938, 10.1002/jbm.b.31478 Regnier-Delplace, 2013, PLGA microparticles with zero-order release of the labile anti-Parkinson drug apomorphine, Int. J. Pharm., 443, 68, 10.1016/j.ijpharm.2013.01.008 Zolnik, 2008, Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres, J. Control. Release, 127, 137, 10.1016/j.jconrel.2008.01.004 Nie, 2010, Paclitaxel and suramin-loaded core/shell microspheres in the treatment of brain tumors, Biomaterials, 31, 8732, 10.1016/j.biomaterials.2010.07.080 Nie, 2010, Core/shell microspheres via coaxial electrohydrodynamic atomization for sequential and parallel release of drugs, J. Biomed. Mater. Res. A, 95, 709, 10.1002/jbm.a.32867 Choi, 2010, Fabrication of core-shell microcapsules using PLGA and alginate for dual growth factor delivery system, J. Control. Release, 147, 193, 10.1016/j.jconrel.2010.07.103 Zheng, 2009, A water-in-oil-in-oil-in-water (W/O/O/W) method for producing drug-releasing, double-walled microspheres, Int. J. Pharm., 374, 90, 10.1016/j.ijpharm.2009.03.015 Tan, 2005, Fabrication of double-walled microspheres for the sustained release of doxorubicin, J. Colloid Interface Sci., 291, 135, 10.1016/j.jcis.2005.04.089 Pollauf, 2005, Small-molecule release from poly(d,l-lactide)/poly(d,l-lactide-co-glycolide) composite microparticles, J. Pharm. Sci., 94, 2013, 10.1002/jps.20408 Berkland, 2004, Three-month, zero-order piroxicam release from monodispersed double-walled microspheres of controlled shell thickness, J. Biomed. Mater. Res. A, 70, 576, 10.1002/jbm.a.30114 Berkland, 2004, Uniform double-walled polymer microspheres of controllable shell thickness, J. Control. Release, 96, 101, 10.1016/j.jconrel.2004.01.018 Rahman, 2004, Localization of bovine serum albumin in double-walled microspheres, J. Control. Release, 94, 163, 10.1016/j.jconrel.2003.10.010 Lee, 2002, Double-walled microspheres for the sustained release of a highly water soluble drug: characterization and irradiation studies, J. Control. Release, 83, 437, 10.1016/S0168-3659(02)00235-3 Lee, 2015, Delivery of doxorubicin and paclitaxel from double-layered microparticles: the effects of layer thickness and dual-drug vs. single-drug loading, Acta Biomater., 27, 53, 10.1016/j.actbio.2015.08.051 Lee, 2014, Inhibition of 3-D tumor spheroids by timed-released hydrophilic and hydrophobic drugs from multilayered polymeric microparticles, Small, 10, 3986, 10.1002/smll.201400536 Xu, 2013, Coaxial electrohydrodynamic atomization process for production of polymeric composite microspheres, Chem. Eng. Sci., 104, 330, 10.1016/j.ces.2013.09.020 Davoodi, 2017, Effective co-delivery of nutlin-3a and p53 genes via core-shell microparticles for disruption of MDM2-p53 interaction and reactivation of p53 in hepatocellular carcinoma, J. Mater. Chem. B, 5, 5816, 10.1039/C7TB00481H Kim, 2011, Synthesis of biodegradable triple-layered capsules using a triaxial electrospray method, Polymer, 52, 3325, 10.1016/j.polymer.2011.05.033 Lee, 2011, Multidrug encapsulation by coaxial tri-capillary electrospray, Colloids Surf. B: Biointerfaces, 82, 104, 10.1016/j.colsurfb.2010.08.022 Xia, 2013, Protein encapsulation in and release from monodisperse double-wall polymer microspheres, J. Pharm. Sci., 102, 1601, 10.1002/jps.23511 Xu, 2013, Combined modality doxorubicin-based chemotherapy and chitosan-mediated p53 gene therapy using double-walled microspheres for treatment of human hepatocellular carcinoma, Biomaterials, 34, 5149, 10.1016/j.biomaterials.2013.03.044 Xia, 2013, Controlled protein release from monodisperse biodegradable double-wall microspheres of controllable shell thickness, J. Control. Release, 172, 707, 10.1016/j.jconrel.2013.08.009 Xu, 2012, Monodisperse double-walled microspheres loaded with chitosan-p53 nanoparticles and doxorubicin for combined gene therapy and chemotherapy, J. Control. Release, 163, 130, 10.1016/j.jconrel.2012.08.032 Xu, 2013, Mechanism of drug release from double-walled PDLLA(PLGA) microspheres, Biomaterials, 34, 3902, 10.1016/j.biomaterials.2013.02.015 Lee, 2010, Formation and degradation of biodegradable triple-layered microparticles, Macromol. Rapid Commun., 31, 1193, 10.1002/marc.200900811 Wang, 2015, Early controlled release of peroxisome proliferator-activated receptor beta/delta agonist GW501516 improves diabetic wound healing through redox modulation of wound microenvironment, J. Control. Release, 197, 138, 10.1016/j.jconrel.2014.11.001 Lee, 2012, Designing multilayered particulate systems for tunable drug release profiles, Acta Biomater., 8, 2271, 10.1016/j.actbio.2012.02.007 Lee, 2012, Designing drug-loaded multi-layered polymeric microparticles, J. Mater. Sci. Mater. Med., 23, 81, 10.1007/s10856-011-4508-z Lee, 2011, Altering the drug release profiles of double-layered ternary-phase microparticles, J. Control. Release, 151, 229, 10.1016/j.jconrel.2011.02.012 Brambilla, 2014, Breakthrough discoveries in drug delivery technologies: the next 30 years, J. Control. Release, 190, 9, 10.1016/j.jconrel.2014.03.056 Park, 2014, Controlled drug delivery systems: past forward and future back, J. Control. Release, 190, 3, 10.1016/j.jconrel.2014.03.054 Nainwal, 2012, Chronotherapeutics — a chronopharmaceutical approach to drug delivery in the treatment of asthma, J. Control. Release, 163, 353, 10.1016/j.jconrel.2012.09.012 Youan, 2010, Chronopharmaceutical drug delivery systems: hurdles, hype or hope?, Adv. Drug Deliv. Rev., 62, 898, 10.1016/j.addr.2010.04.010 Youan, 2004, Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery?, J. Control. Release, 98, 337, 10.1016/j.jconrel.2004.05.015 Powell, 1996, Drug delivery issues in vaccine development, Pharm. Res., 13, 1777, 10.1023/A:1016064504346 Heller, 1993, Modulated release from drug delivery devices, Crit. Rev. Ther. Drug Carrier Syst., 10, 253 Stubbe, 2004, “Programmed polymeric devices” for pulsed drug delivery, Pharm. Res., 21, 1732, 10.1023/B:PHAM.0000045223.45400.01 Mandal, 2010, Drug delivery system based on chronobiology—a review, J. Control. Release, 147, 314, 10.1016/j.jconrel.2010.07.122 Timko, 2010, Remotely triggerable drug delivery systems, Adv. Mater., 22, 4925, 10.1002/adma.201002072 Mattis, 2016, Circadian rhythms, sleep, and disorders of aging, Trends Endocrinol. Metab., 27, 192, 10.1016/j.tem.2016.02.003 Douma, 2018, Free Radic. Biol. Med., 119, 108 Logan, 2018, Impact of sleep and circadian rhythms on addiction vulnerability in adolescents, Biol. Psychiatry, 83, 987, 10.1016/j.biopsych.2017.11.035 Rosenberg, 1980, Rhythmic dentinogenesis in the rabbit incisor: circadian, ultradian, and infradian periods, Calcif. Tissue Int., 32, 29, 10.1007/BF02408519 Smolensky, 2007, Chronobiology, drug delivery, and chronotherapeutics, Adv. Drug Deliv. Rev., 59, 828, 10.1016/j.addr.2007.07.001 Roy, 2009, Multiparticulate formulation approach to pulsatile drug delivery: current perspectives, J. Control. Release, 134, 74, 10.1016/j.jconrel.2008.11.011 Lévi, 2007, Implications of circadian clocks for the rhythmic delivery of cancer therapeutics, Adv. Drug Deliv. Rev., 59, 1015, 10.1016/j.addr.2006.11.001 Altinok, 2007, A cell cycle automaton model for probing circadian patterns of anticancer drug delivery, Adv. Drug Deliv. Rev., 59, 1036, 10.1016/j.addr.2006.09.022 Hori, 1992, Circadian variation of tumor blood flow in rat subcutaneous tumors and its alteration by angiotensin II-induced hypertension, Cancer Res., 52, 912 Hori, 1996, Timing of cancer chemotherapy based on circadian variations in tumor tissue blood flow, Int. J. Cancer, 65, 360, 10.1002/(SICI)1097-0215(19960126)65:3<360::AID-IJC14>3.0.CO;2-E Saitohl, 2000, Intragastric acidity and circadian rhythm, Biomed Pharmacother, 55, s138, 10.1016/S0753-3322(01)90019-8 Bruguerolle, 2007, Rhythmic pattern in pain and their chronotherapy, Adv. Drug Deliv. Rev., 59, 883, 10.1016/j.addr.2006.06.001 Waldhäusl, 1989, Circadian rhythms of insulin needs and actions, Diabetes Res. Clin. Pract., 6, S17, 10.1016/0168-8227(89)90074-0 Tofler, 1987, Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death, N. Engl. J. Med., 316, 1514, 10.1056/NEJM198706113162405 Portaluppi, 2007, Circadian rhythms in cardiac arrhythmias and opportunities for their chronotherapy, Adv. Drug Deliv. Rev., 59, 940, 10.1016/j.addr.2006.10.011 Portaluppi, 2007, Chronobiology and chronotherapy of ischemic heart disease, Adv. Drug Deliv. Rev., 59, 952, 10.1016/j.addr.2006.07.029 Martin, 1998, Chronobiology of asthma, Am. J. Respir. Crit. Care Med., 158, 1002, 10.1164/ajrccm.158.3.9712132 Smolensky, 2007, Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma, Adv. Drug Deliv. Rev., 59, 852, 10.1016/j.addr.2007.08.016 Haus, 2007, Chronobiology in the endocrine system, Adv. Drug Deliv. Rev., 59, 985, 10.1016/j.addr.2007.01.001 Beauchamp, 2007, Chronobiology and chronotoxicology of antibiotics and aminoglycosides, Adv. Drug Deliv. Rev., 59, 896, 10.1016/j.addr.2006.07.028 Herrlich, 2012, Osmotic micropumps for drug delivery, Adv. Drug Deliv. Rev., 64, 1617, 10.1016/j.addr.2012.02.003 Stevenson, 2012, Reservoir-based drug delivery systems utilizing microtechnology, Adv. Drug Deliv. Rev., 64, 1590, 10.1016/j.addr.2012.02.005 Lee, 2011, An intravesical device for the sustained delivery of lidocaine to the bladder, J. Control. Release, 149, 133, 10.1016/j.jconrel.2010.10.016 Cima, 2011, Microsystem technologies for medical applications, Annu. Rev. Chem. Biomol. Eng., 2, 355, 10.1146/annurev-chembioeng-061010-114120 Payton, 2012, Novel lidocaine delivery device for chronic interstitial cystitis, Nat. Rev. Urol., 9, 546 Berry, 2011, Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States, J. Urol., 186, 540, 10.1016/j.juro.2011.03.132 Nickel, 2012, Continuous intravesical lidocaine treatment for interstitial cystitis/bladder pain syndrome: safety and efficacy of a new drug delivery device, Sci. Transl. Med., 4, 1 Scholz, 2008, Drug delivery from the oral cavity: focus on a novel mechatronic delivery device, Drug Discov. Today, 13, 247, 10.1016/j.drudis.2007.10.018 Velten, 2008, Biocompatible flow sensor with integrated solvent concentration measurement, Sensors Actuators A Phys., 145-146, 257, 10.1016/j.sna.2008.01.008 Moscicka, 2007, IntelliDrug implant for medicine delivery in Alzheimer's disease treatment, Macromol. Symp., 253, 134, 10.1002/masy.200750720 Giannola, 2010, New prospectives in the delivery of galantamine for elderly patients using the IntelliDrug intraoral device: in vivo animal studies, Curr. Pharm. Des., 16, 653, 10.2174/138161210790883804 Campisi, 2010, Bioavailability in vivo of naltrexone following transbuccal administration by an electronically-controlled intraoral device: a trial on pigs, J. Control. Release, 145, 214, 10.1016/j.jconrel.2010.04.027 Lee, 2016, Implantable devices for sustained, intravesical drug delivery, Int. Neurourol. J., 20, 101, 10.5213/inj.1632664.332 http://www.notialdia.net/una-muela-inteligente-para-luchar-contra-el-mal-de-parkinson, 2018. A.O. Pumps Wright, 2001, An in vivo/in vitro comparison with a leuprolide osmotic implant for the treatment of prostate cancer, J. Control. Release, 75, 1, 10.1016/S0168-3659(01)00358-3 Theeuwes, 1976, Principles of the design and operation of generic osmotic pumps for the delivery of semisolid or liquid drug formulations, Ann. Biomed. Eng., 4, 343, 10.1007/BF02584524 Yang, 2008 Cukierski, 2001, Chronic (60-week) toxicity study of DUROS leuprolide implants in dogs, Int. J. Clin. Pharmacol. Ther., 20, 369 Rohloff, 2008, DUROS® technology delivers peptides and proteins at consistent rate continuously for 3 to 12 months, J. Diabetes Sci. Technol., 2, 461, 10.1177/193229680800200316 www.intarcia.com, 19/12/2017. Fisher, 2003, Pharmacokinetics of an implanted osmotic pump delivering sufentanil for the treatment of chronic pain, Anesthesiology, 99, 929, 10.1097/00000542-200310000-00028 http://phx.corporate-ir.net/phoenix.zhtml?c=121590&p=irol-newsArticle&ID=459693&highlight, (19/12/2017). Ryu, 2007, Biodegradable micro-osmotic pump for long-term and controlled release of basic fibroblast growth factor, J. Control. Release, 124, 98, 10.1016/j.jconrel.2007.08.024 Lo, 2009, A passive MEMS drug delivery pump for treatment of ocular diseases, Biomed. Microdevices, 11, 959, 10.1007/s10544-009-9313-9 Li, 2008, An electrochemical intraocular drug delivery device, Sensors Actuators A Phys., 143, 41, 10.1016/j.sna.2007.06.034 Nuxoll, 2009, BioMEMS devices for drug delivery, IEEE Eng. Med. Biol. Mag., 28, 31, 10.1109/MEMB.2008.931014 Matriano, 2002, Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization, Pharm. Res., 19, 63, 10.1023/A:1013607400040 Zahn, 2000, Microfabricated polysilicon microneedles for minimally invasive biomedical devices, Biomed. Microdevices, 2, 295, 10.1023/A:1009907306184 Chandrasekaran, 2003, Surface micromachined metallic microneedles, J. Microelectromech. Syst., 12, 281, 10.1109/JMEMS.2003.809951 Zahn, 2004, Continuous on-chip micropumping for microneedle enhanced drug delivery, Biomed. Microdevices, 6, 183, 10.1023/B:BMMD.0000042047.83433.96 Cleland, 1998, Development of a single-shot subunit vaccine for HIV-1. 5. Programmable in vivo autoboost and long lasting neutralizing response, J. Pharm. Sci., 87, 1489, 10.1021/js980263f Cleland, 1996, Development of a single-shot subunit vaccine for HIV-1. 3. Effect of adjuvant and immunization schedule on the duration of the humoral immune response to recombinant MN gp120, J. Pharm. Sci., 85, 1350, 10.1021/js960329b Cleland, 1996, Development of a single-shot subunit vaccine for HIV-1. 2. Defining optimal autoboost characteristics to maximize the humoral immune response, J. Pharm. Sci., 85, 1346, 10.1021/js960047b Cleland, 1994, Development of a single-shot subunit vaccine for HIV-1, AIDS Res. Hum. Retrovir., 10, S21 Rosas, 2002, Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres, Vaccine, 20, 1707, 10.1016/S0264-410X(01)00508-4 Ye, 2010, Issues in long-term protein delivery using biodegradable microparticles, J. Control. Release, 146, 241, 10.1016/j.jconrel.2010.05.011 Davoodi, 2016, Double-walled microparticles-embedded self-cross-linked, injectable, and antibacterial hydrogel for controlled and sustained release of chemotherapeutic agents, ACS Appl. Mater. Interfaces, 8, 22785, 10.1021/acsami.6b03041 Davoodi, 2017, Codelivery of anti-cancer agents via double-walled polymeric microparticles/injectable hydrogel: a promising approach for treatment of triple negative breast cancer, Biotechnol. Bioeng., 114, 2931, 10.1002/bit.26406 Sanchez, 1996, Pulsed controlled-released system for potential use in vaccine delivery, J. Pharm. Sci., 85, 547, 10.1021/js960069y Khoo, 1994, Veterinary implants for delayed pulsed release of antigen, 21, 116 Gilam, 2016, Local microRNA delivery targets palladin and prevents metastatic breast cancer, Nat. Commun., 7, 1 Conde, 2016, Self-assembled RNA-triple-helix hydrogel scaffold for microRNA modulation in the tumour microenvironment, Nat. Mater., 15, 353, 10.1038/nmat4497 Franssen, 1999, Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres, J. Control. Release, 60, 211, 10.1016/S0168-3659(99)00074-7 Göpferich, 1997, Bioerodible implants with programmable drug, J. Control. Release, 44, 271, 10.1016/S0168-3659(96)01533-7 Wuthrich, 1992, Pulsatile and delayed release of lysozyme from ointment-like poly(ortho esters), J. Control. Release, 21, 191, 10.1016/0168-3659(92)90021-I Rothstein, 2009, A unified mathematical model for the prediction of controlled release from surface and bulk eroding polymer matrices, Biomaterials, 30, 1657, 10.1016/j.biomaterials.2008.12.002 Kumar, 2002, Polyanhydrides: an overview, Adv. Drug Deliv. Rev., 54, 889, 10.1016/S0169-409X(02)00050-9 Gao, 1998, Surface modification of polyanhydride microspheres, J. Pharm. Sci., 87, 246, 10.1021/js970284u Tamargo, 1993, Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain, Cancer Res., 53, 329 Domb, 1994, 10 - polymeric drug carrier systems in the brain, 169, 10.1016/B978-0-12-185291-7.50016-3 Kubek, 1998, Prolonged seizure suppression by a single implantable polymeric-TRH microdisk preparation, Brain Res., 809, 189, 10.1016/S0006-8993(98)00860-9 Domb, 1996 Wu, 2000, Novel nanoparticles formed via self-assembly of poly(ethylene glycol-b-sebacic anhydride) and their degradation in water, Macromolecules, 33, 9040, 10.1021/ma000989+ Medlicott, 1999, Pulsatile release from subcutaneous implants, Adv. Drug Deliv. Rev., 38, 139, 10.1016/S0169-409X(99)00013-7 Gopferich, 1997, Erosion of composite polymer matrices, Biomaterials, 18, 397, 10.1016/S0142-9612(96)00151-2 Göpferich, 1996, Mechanisms of polymer degradation and erosion, Biomaterials, 17, 103, 10.1016/0142-9612(96)85755-3 Jiang, 2000, Pulsatile protein release from a laminated device comprising polyanhydrides and pH-sensitive complexes, Int. J. Pharm., 194, 51, 10.1016/S0378-5173(99)00336-1 Dang, 2017, Local pulsatile PTH delivery regenerates bone defects via enhanced bone remodeling in a cell-free scaffold, Biomaterials, 114, 1, 10.1016/j.biomaterials.2016.10.049 Adams, 2013, Drug delivery systems for the treatment of diabetes mellitus: state of the art, Curr. Pharm. Des., 19, 7244, 10.2174/13816128113199990367 Rai, 2016, Novel drug delivery system: an immense hope for diabetics, Drug Deliv., 23, 2371, 10.3109/10717544.2014.991001 Webber, 2015, Smart approaches to glucose-responsive drug delivery, J. Drug Target., 23, 651, 10.3109/1061186X.2015.1055749 Yu, 2016, Stimuli-responsive delivery of therapeutics for diabetes treatment, Bioeng. Transl. Med., 1, 323, 10.1002/btm2.10036 Ding, 1715, Recent advances in stimuli-responsive release function drug delivery systems for tumor treatment, Molecules, 21, 1 Yao, 2016, External-stimuli responsive systems for cancer theranostic, Asian J. Pharm. Sci., 11, 585, 10.1016/j.ajps.2016.06.001 Alexandrov, 2004, Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke, N. Engl. J. Med., 351, 2170, 10.1056/NEJMoa041175 Mura, 2013, Stimuli-responsive nanocarriers for drug delivery, Nat. Mater., 12, 991, 10.1038/nmat3776 Kang, 2011, Near-infrared light-responsive core–shell nanogels for targeted drug delivery, ACS Nano, 5, 5094, 10.1021/nn201171r Chung, 1999, Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly (N-isopropylacrylamide) and poly (butylmethacrylate), J. Control. Release, 62, 115, 10.1016/S0168-3659(99)00029-2 Murdan, 2003, Electro-responsive drug delivery from hydrogels, J. Control. Release, 92, 1, 10.1016/S0168-3659(03)00303-1 Hayashi, 2010, High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect, ACS Appl. Mater. Interfaces, 2, 1903, 10.1021/am100237p Chen, 2013, Ultrasound and pH dually responsive polymer vesicles for anticancer drug delivery, Sci. Rep., 3, 1 Tao, 2014, Stimuli-responsive copolymers and their applications, 274 Gil, 2004, Stimuli-responsive polymers and their bioconjugates, Prog. Polym. Sci., 29, 1173, 10.1016/j.progpolymsci.2004.08.003 Yoshida, 1994, Positive thermosensitive pulsatile drug release using negative thermosensitive hydrogels, J. Control. Release, 32, 97, 10.1016/0168-3659(94)90229-1 Coughlan, 2004, Effect of drug physicochemical properties on swelling/deswelling kinetics and pulsatile drug release from thermoresponsive poly (N-isopropylacrylamide) hydrogels, J. Control. Release, 98, 97, 10.1016/j.jconrel.2004.04.014 Kikuchi, 2002, Pulsatile drug release control using hydrogels, Adv. Drug Deliv. Rev., 54, 53, 10.1016/S0169-409X(01)00243-5 Cheng, 2015, Oxidation- and thermo-responsive poly(N-isopropylacrylamide-co-2-hydroxyethyl acrylate) hydrogels cross-linked via diselenides for controlled drug delivery, RSC Adv., 5, 4162, 10.1039/C4RA13500H Agrawal, 2012, In situ gel systems as ‘smart’carriers for sustained ocular drug delivery, Expert Opin. Drug Deliv., 9, 383, 10.1517/17425247.2012.665367 Purslow, 2005, Ocular surface temperature: a review, Eye Contact Lens, 31, 117, 10.1097/01.ICL.0000141921.80061.17 Wade, 1994, Methylcellulose, 306 McBride, 2004 Santini, 2004 Lindner, 2008, Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug release, J. Control. Release, 125, 112, 10.1016/j.jconrel.2007.10.009 Landon, 2011, Nanoscale drug delivery and hyperthermia: the materials design and preclinical and clinical testing of low temperature-sensitive liposomes used in combination with mild hyperthermia in the treatment of local cancer, Open Nanomedicine J., 3, 1, 10.2174/1875933501103010038 Kneidl, 2014, Thermosensitive liposomal drug delivery systems: state of the art review, Int. J. Nanomedicine, 9, 4387 Jiang, 2006, Toward photocontrolled release using light-dissociable block copolymer micelles, Macromolecules, 39, 4633, 10.1021/ma060142z Mochizuki-Oda, 2002, Effects of near-infra-red laser irradiation on adenosine triphosphate and adenosine diphosphate contents of rat brain tissue, Neurosci. Lett., 323, 207, 10.1016/S0304-3940(02)00159-3 Bisby, 2000, Wavelength-programmed solute release from photosensitive liposomes, Biochem. Biophys. Res. Commun., 276, 169, 10.1006/bbrc.2000.3456 Nagasaki, 2007, The concept of molecular machinery is useful for design of stimuli-responsive gene delivery systems in the mammalian cell, J. Incl. Phenom. Macrocycl. Chem., 58, 205, 10.1007/s10847-007-9303-6 Welch, 2011 Steiner, 2011, Laser-tissue interactions, 23 Tuchin, 1997, Light scattering study of tissues, Physics-Uspekhi, 40, 495, 10.1070/PU1997v040n05ABEH000236 William, 1949, The absorption spectra and extinction coefficients of myoglobin, J. Biol. Chem., 179, 235, 10.1016/S0021-9258(18)56832-0 Simpson, 1998, Near-infrared optical properties of ex vivo human skin and subcutaneous tissues measured using the Monte Carlo inversion technique, Phys. Med. Biol., 43, 2465, 10.1088/0031-9155/43/9/003 Alkilany, 2012, Gold nanorods: their potential for photothermal therapeutics and drug delivery, tempered by the complexity of their biological interactions, Adv. Drug Deliv. Rev., 64, 190, 10.1016/j.addr.2011.03.005 Vivero-Escoto, 2009, Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere, J. Am. Chem. Soc., 131, 3462, 10.1021/ja900025f von Maltzahn, 2009, Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas, Cancer Res., 69, 3892, 10.1158/0008-5472.CAN-08-4242 Santini, 2006 Stevenson, 2015, Development of combination product drug delivery systems, 66 Schmidt-Erfurth, 2000, Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration, Surv. Ophthalmol., 45, 195, 10.1016/S0039-6257(00)00158-2 Pankhurst, 2003, Applications of magnetic nanoparticles in biomedicine, J. Phys. D. Appl. Phys., 36, R167, 10.1088/0022-3727/36/13/201 Grief, 2005, Mathematical modelling of magnetically targeted drug delivery, J. Magn. Magn. Mater., 293, 455, 10.1016/j.jmmm.2005.02.040 Hsieh, 1981, Magnetic modulation of release of macromolecules from polymers, Proc. Natl. Acad. Sci. U. S. A., 78, 1863, 10.1073/pnas.78.3.1863 Edelman, 1985, Regulation of drug release from polymer matrices by oscillating magnetic fields, J. Biomed. Mater. Res. A, 19, 67, 10.1002/jbm.820190107 Pirmoradi, 2011, On-demand controlled release of docetaxel from a battery-less MEMS drug delivery device, Lab Chip, 11, 2744, 10.1039/c1lc20134d Gil, 2010, Nanopharmacy: inorganic nanoscale devices as vectors and active compounds, Pharmacol. Res., 62, 115, 10.1016/j.phrs.2010.01.009 Handy, 2006 Ishikawa, 2016 Cai, 2009, Magnetically triggered reversible controlled drug delivery from microfabricated polymeric multireservoir devices, Adv. Mater., 21, 4045, 10.1002/adma.200900593 Huang, 2009, A flexible drug delivery chip for the magnetically-controlled release of anti-epileptic drugs, J. Control. Release, 139, 221, 10.1016/j.jconrel.2009.07.002 Scranton, 1995, Biomedical applications of polyelectrolytes, 1 Pierce, 2010, Transdermal delivery of sumatriptan for the treatment of acute migraine, Neurotherapeutics, 7, 159, 10.1016/j.nurt.2010.03.005 Mattia, 2007, Acute postoperative pain management: focus on iontophoretic transdermal fentanyl, Ther. Clin. Risk Manag., 3, 19, 10.2147/tcrm.2007.3.1.19 Zempsky, 2004, Evaluation of a low-dose lidocaine lontophoresis system for topical anesthesia in adults and children: a randomized, controlled trial, Clin. Ther., 26, 1110, 10.1016/S0149-2918(04)90183-X Viscusi, 2004, Patient-controlled transdermal fentanyl hydrochloride vs intravenous morphine pump for postoperative pain: a randomized controlled trial, JAMA, 291, 1333, 10.1001/jama.291.11.1333 Low, 2000, Microactuators toward microvalves for responsive controlled drug delivery, Sensors Actuators B Chem., 67, 149, 10.1016/S0925-4005(00)00396-8 Singh, 2010, Transcleral delivery of triamcinolone acetonide and ranibizumab to retinal tissues using macroesis, Br. J. Ophthalmol., 94, 170, 10.1136/bjo.2009.159541 Uhland, 2004 Minkowitz, 2007, Fentanyl iontophoretic transdermal system: a review, Tech. Reg. Anesth. Pain. Manag., 11, 3, 10.1053/j.trap.2007.02.001 Mitragotri, 2005, Healing sound: the use of ultrasound in drug delivery and other therapeutic applications, Nat. Rev. Drug Discov., 4, 255, 10.1038/nrd1662 Jones, 2007, Steps on the road to personalized medicine, Nat. Rev. Drug Discov., 6, 770, 10.1038/nrd2434 Hamburg, 2010, The path to personalized medicine, N. Engl. J. Med., 301, 10.1056/NEJMp1006304 Grayson, 2003, Multi-pulse drug delivery from a resorbable polymeric microchip device, Nat. Mater., 2, 767, 10.1038/nmat998 Prescott, 2006, Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device, Nat. Biotechnol., 24, 437, 10.1038/nbt1199 Farra, 2012, First-in-human testing of a wirelessly controlled drug delivery microchip, Sci. Transl. Med., 4, 1, 10.1126/scitranslmed.3003276 Maloney, 2005, Electrothermally activated microchips for implantable drug delivery and biosensing, J. Control. Release, 109, 244, 10.1016/j.jconrel.2005.09.035 Santini, 1999, A controlled-release microchip, Nature, 397, 335, 10.1038/16898 Xu, 2009, Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow-focusing device for controlled drug delivery, Small, 5, 1575, 10.1002/smll.200801855 He, 1999, Chitosan microspheres prepared by spray drying, Int. J. Pharm., 187, 53, 10.1016/S0378-5173(99)00125-8 Mu, 2001, Fabrication, characterization and in vitro release of paclitaxel (Taxol) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers, J. Control. Release, 76, 239, 10.1016/S0168-3659(01)00440-0 Benoit, 1999, Preparation and characterization of protein-loaded poly(epsilon-caprolactone) microparticles for oral vaccine delivery, Int. J. Pharm., 184, 73, 10.1016/S0378-5173(99)00109-X Kim, 2006, Microspheres for drug delivery, 19 Berkland, 2004, Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres, J. Control. Release, 94, 129, 10.1016/j.jconrel.2003.09.011 Berkland, 2003, PLG microsphere size controls drug release rate through several competing factors, Pharm. Res., 20, 1055, 10.1023/A:1024466407849 Siepmann, 2004, Effect of the size of biodegradable microparticles on drug release: experiment and theory, J. Control. Release, 96, 123, 10.1016/j.jconrel.2004.01.011 Boehm, 2014, Inkjet printing for pharmaceutical applications, Mater. Today, 17, 247, 10.1016/j.mattod.2014.04.027 Scoutaris, 2011, Inkjet printing as a novel medicine formulation technique, J. Control. Release, 156, 179, 10.1016/j.jconrel.2011.07.033 Genina, 2012, Tailoring controlled-release oral dosage forms by combining inkjet and flexographic printing techniques, Eur. J. Pharm. Sci., 47, 615, 10.1016/j.ejps.2012.07.020 Kolakovic, 2013, Printing technologies in fabrication of drug delivery systems, Expert Opin. Drug Deliv., 10, 1711, 10.1517/17425247.2013.859134 Lewis, 2010 Rowe, 2000, Multimechanism oral dosage forms fabricated by three dimensional printing, J. Control. Release, 66, 11, 10.1016/S0168-3659(99)00224-2 Lewis, 2007 Prasad, 2016, 3D printing technologies for drug delivery: a review, Drug Dev. Ind. Pharm., 42, 1019, 10.3109/03639045.2015.1120743 Gross, 2014, Evaluation of 3D printing and its potential impact on biotechnology and the chemical sciences, Anal. Chem., 86, 3240, 10.1021/ac403397r Goyanes, 2015, Effect of geometry on drug release from 3D printed tablets, Int. J. Pharm., 494, 657, 10.1016/j.ijpharm.2015.04.069 Yu, 2008, Three-dimensional printing in pharmaceutics: promises and problems, J. Pharm. Sci., 97, 3666, 10.1002/jps.21284 Sun, 2015, Printing tablets with fully customizable release profiles for personalized medicine, Adv. Mater., 27, 7847, 10.1002/adma.201504122